Innopharmax Inc banner
I

Innopharmax Inc
TPEX:4172

Watchlist Manager
Innopharmax Inc
TPEX:4172
Watchlist
Price: 11.15 TWD -2.62% Market Closed
Market Cap: NT$1.3B

Wall St Price Targets

Price Targets Summary
Innopharmax Inc

There are no price targets for Innopharmax Inc.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Innopharmax Inc Competitors:
Price Targets
SPH
Suburban Propane Partners LP
89% Upside

Revenue
Forecast

20% / Year
Past Growth
4% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
20% / Year
Past Growth
4% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 11 years is 4%.

Gross Profit
Forecast

33% / Year
Past Growth
3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
33% / Year
Past Growth
3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 33%. The projected CAGR for the next 11 years is 3%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Innopharmax Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Innopharmax Inc's stock price target?
Not Available

Innopharmax Inc does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Innopharmax Inc?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 11 years is 4%.

What is the Gross Profit forecast for Innopharmax Inc?
Projected CAGR
3%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 33%. The projected CAGR for the next 11 years is 3%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett